Komjathy Andrew — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Komjathy Andrew is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Andrew Komjathy is identified as the Chief Commercial Officer of Astria Therapeutics, Inc. in SEC filing CIK 0001788465 dated 2026-01-23, with no reported purchases or sales. Astria Therapeutics is a biopharmaceutical company focused on therapies for rare allergic and immunological diseases, and Komjathy leads the company's commercial strategy as it advances STAR-0215 and STAR-0310 preclinical programs.
Role
Insider
Notability
40/100
Board memberships
Astria Therapeutics, Inc.
Awards & honors
Appointed Chief Commercial Officer at Astria Therapeutics, as evidenced by SEC filing on 2026-01-23 (CIK 0001788465).
Andrew Komjathy is identified as the Chief Commercial Officer of Astria Therapeutics, Inc. in SEC filing CIK 0001788465 dated 2026-01-23, with no reported purchases or sales. Astria Therapeutics is a biopharmaceutical company focused on therapies for rare allergic and immunological diseases, and Komjathy leads the company's commercial strategy as it advances STAR-0215 and STAR-…
Where can I see all of Komjathy Andrew's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
